Effect of imipramine on depression and immune status in a sample of men with HIV infection
- 1 April 1990
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 147 (4) , 495-497
- https://doi.org/10.1176/ajp.147.4.495
Abstract
Eleven men with major depression and human immunodeficiency virus (HIV) infection underwent an open trial of imipramine. Eight of nine (89%) who completed 12 weeks responded. The mean decline in T4 cells from baseline was 100 at week 12 and 16 at week 26. No major exacerbations of HIV infection occurred.This publication has 9 references indexed in Scilit:
- Immune cell parameters in severely depressed patients: negative findingsJournal of Affective Disorders, 1989
- CD4 PERCENTAGE, CD4 NUMBER, AND CD4-CD8 RATIO IN HIV INFECTION - WHICH TO CHOOSE AND HOW TO USE1989
- Major Depressive Disorder and ImmunityArchives of General Psychiatry, 1989
- PREDICTORS OF DECLINE IN CD4 LYMPHOCYTES IN A COHORT OF HOMOSEXUAL MEN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS1988
- Alterations in immunocompetence during stress, bereavement, and depression: focus on neuroendocrine regulationAmerican Journal of Psychiatry, 1987
- A preliminary report on anti-depressant therapy and its effects on hope and immunitySocial Science & Medicine, 1985
- A controlled study of cellular immune function in affective disorders before and during somatic therapyPsychiatry Research, 1985
- Depression and ImmunityArchives of General Psychiatry, 1985
- Impaired lymphocyte function in depressive illnessLife Sciences, 1983